Intelligent triage: a vital step toward resolving the problem of capacity in NHS cancer...
AI offers an opportunity to reimagine our approach to cancer diagnostics, leveraging data to build a more robust and efficient system for cancer referrals.
Can AI be used to predict and prevent breast cancer?
Lester Litchfield, Head of Data Science at Volpara Health, discusses the future of artificial intelligence in breast health.
Machine learning and prognostics in cancer programmes
Tim Simpson, General Manager of Hologic UK & Ireland, discusses how AI, machine learning and prognostics could revolutionise cancer detection and treatment in breast and cervical cancer programmes.
Can technology help detect brain tumours through urine analysis?
Researchers have revealed a new and non-invasive way to detect brain tumours through a device that identifies a key membrane protein in a patient's urine.
Addressing the chasm in UK cancer care
Stefan Doroszkowski, Managing Director at Amethyst Radiotherapy Group UK, shares his stance on responding to the cancer care crisis, addressing the chasm in UK cancer care.
Cancer vaccine trials encourage personalised immunotherapies
A new partnership will help accelerate clinical trials across the UK for a cancer vaccine with the potential for personalised immunotherapies.
How integrative oncology is transforming cancer care
Santosh Rao, Channing J. Paller, Ana Maria Lopez, Eugene Ahn, Jodi MacLeod, Ting Bao, and Linda E. Carlson, from the Society for Integrative Oncology, detail how integrative oncology is transforming cancer care.
Exploring the human epidermal growth factor receptor 2 (HER2)
Gail Dianne Lewis, the Senior Principal Scientist at Discovery Oncology Genentech, Inc. analyses the human epidermal growth factor receptor 2.
Innovative approaches to cancer treatments oncological engineering
Prof Richard M Hall, School of Mechanical Engineering, University of Leeds, explores how oncological engineering is paving the way for new and innovative cancer treatments.
AI for mammography performance and quality enhancement
Lisa Johnston, PhD, Product Expert at Volpara Health, explains the use of AI for mammography performance and quality enhancement.
The two main types of skin cancer
British Skin Foundation walk us through the two main types of skin cancer, melanoma & non-melanoma, and the importance of funding research in the field.
Cancer research: The only way to avoid a cancer epidemic
Dr Lynn Turner, Director of Research at Worldwide Cancer Research, states that cancer research is the only way to avoid a cancer epidemic.
Potential cancer vaccine shows promise in animal trials
Investigators from the National Institute of Allergy and Infectious Diseases (NIAID) have announced an experimental therapeutic cancer vaccine.
Cancer research: A Canadian healthcare perspective
The Canadian Institutes of Health Research (CIHR), a Canadian healthcare research investment agency, collaborates with partners to innovate health improvements.
Rethinking cancer as a molecular and cellular ecosystem
Sean Lawler, Associate Professor at Brown University pursues an understanding of cancer through the lens of the molecular and cellular ecosystem and natural selection.
Why do some cancer patients not respond to immunotherapy?
Only half of patients with colorectal and endometrial cancer respond to immunotherapy, which is designed to recognise and attack cancer cells
Precision radiotherapy: Our most effective cancer treatment
David Bloomfield, Consultant in Clinical Oncology Sussex Cancer Centre, argues that precision radiotherapy is our most effective cancer treatment and should be available to everyone with cancer, but workforce planning is failing our patients.
Launching a real-time AI solution for early throat cancer detection
Marius Wellenstein, COO and co-Founder of WSK Medical, explains the successful launch and implementation of Zeno AI, a real-time AI solution for early throat cancer detection.
Preventable asbestos cancer – mesothelioma
Asbestos in over 300,000 public sector buildings continues to put lives at risk. Recommendations to the government for its removal over the next 40 years have been ignored, says Liz Darlison of Mesothelioma UK and Helen Childs, Partner at RWK Goodman.
Artificial Intelligence implementation & cancer research
Dr Zisis Kozlakidis & Eduardo Mascarenhas turn the spotlight on Artificial Intelligence implementation and cancer research.
